Follow
Vicore Pharma Holding AB
Vicore Pharma Holding AB is a drug development company. The company's through is subsidiary is developing a new type of pharmaceutical compound, known as AT2R agonists, to stimulate the AT2 receptor within the Renin-Angiotensin system. Its lead drug candidate, C21, is the first small molecule compound in its class.
Status
This company has moved to a main market, therfore we do not show updates relating to this company.
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
VICO
SE0007577895
Details of share in Vicore Pharma Holding AB with ticker VICO
Status
Active
Order book id
Amount of instruments
42 374 714
Par value
0.5000
Currency
SEK
First trading date
10 Dec 2015
Type
Price
Pre-money
Time
Files
IPO
6.00 SEK
48.7M SEK
29 Oct - 16 Nov 2015
-
IPO in Vicore Pharma Holding AB
Type
Price
Pre-money
Time
Files
Targeted issue
16.00 SEK
23 Feb - 23 Feb 2017
-
Share issue in Vicore Pharma Holding AB
Type
Price
Pre-money
Time
Files
New issue
10.00 SEK
247.2M SEK
19 Sep - 01 Oct 2018
Share issue in Vicore Pharma Holding AB
Type
Price
Pre-money
Time
Files
Targeted issue
17.00 SEK
560.3M SEK
30 Nov - 30 Nov 2018
-
Share issue in Vicore Pharma Holding AB
Type
Price
Pre-money
Time
Files
Market move
27 Sep 2019
Listing of Vicore Pharma Holding AB on NASDAQ STOCKHOLM
People
Carl Johan Dalsgaard
CEO
Leif Darner
Chairman of the board
Kjell Stenberg
Board member
Peter Ström
Board member
Göran Wessman
Board member
Jacob Gunterberg
Board member
Hans Schikan
Board member
Maarten Kraan
Board member
Sara Malcus
Board member
Company Details
Sector

Address
Kronhusgatan 11
Zip code
411 05
City/district
Göteborg
Country
Sweden (SE)
Registration number
556680-3804
LEI code
549300KTNBPTZLF01130
First trade date
10 Dec 2015
Registration date
10 May 2005
Short name
Vicore Pharma

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More